Mangoceuticals Inc
MGRX
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.61M
Close$
$-0.29
181.5% downside
Current Fair Value
181.5% downsideOvervalued by 181.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.61 Million |
|---|---|
| Enterprise Value | $3.97 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.05 |
| Beta | 2.27 |
| Outstanding Shares | 10,071,609 |
Return
| Return on Equity | -142.53% |
|---|---|
| Return on Assets | -132.93% |
| Return on Invested Capital | -120.94% |
Valuation & Multiples
| P/E Ratio | -0.19 |
|---|---|
| PEG | 0.63 |
| Price to Sales | - |
| Price to Book Ratio | 0.36 |
| Enterprise Value to Revenue | 15.08 |
| Enterprise Value to EBIT | -0.24 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 19, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 8.21%▼ 16.98% |
|---|---|
| Total Invested | $297,620▼ 84.15% |
| Investors Holding | 180% |
ESG Score
No data